The Cleveland Clinic Foundation

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Lung cancer1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Conjupro Biotherapeutics, Inc.1 trial
• Syndax Pharmaceuticals1 trial

Running trials

• Recruiting

  A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  NCT04710576· Phase 2· Syndax Pharmaceuticals· Source

  Contact: Syndax Pharmaceuticals

Closed trials

• Terminated

  Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

  NCT04931823· Phase 1· Conjupro Biotherapeutics, Inc.· Source